Description:
This interactive and informative course provides a comprehensive overview of the planning and implementation of phase III and phase IV oncology clinical trials. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates can learn to design trials to minimize the deficiencies that lead to inappropriate interpretation whilst maximizing the competitive advantage. In addition, delegates will benefit from the perspective and experience of the regulatory bodies on EU oncology directives.
Case studies, worked examples and discussion sessions are inherent throughout this two-day course, encouraging a lively and positive learning environment.
Topics include:
- Introduction to oncology clinical trial design and planning
- Informed consent
- How trials impact on clinical practice
- Statistical analysis and reporting
- Worked examples of clinical trials
- Meta-analysis
- Quality of life assessment
Who Should Attend:
This course is suitable for pharmaceutical industry personnel working in the area of oncology, including those from clinical research, medical affairs and regulatory functions, as well as individuals in strategic marketing and business functions.
CPD Accreditation:
Healthcare’s programs are approved by the Faculty of Pharmaceutical Medicine for CPD accreditation. Details can be supplied on request.
Course Instructors:
Mace L Rothenberg MD
Professor of Medicine and Ingram Professor of Cancer Research
Vanderbilt-Ingram Cancer Center
Nashville, USA
Donald Berry MD
Head, Division of Quantitative Sciences
& Chairman, Department of Biostatistics
M.D. Anderson Cancer Center
University of Texas
Houston, USA
Cindy Billingham MD
Head of Biostatistics
CR UK Clinical Trials Unit
University of Birmingham
Birmingham UK
Jeffrey Crawford MD
George Barth Geller Professor for Research in Cancer
Chief of Medical Oncology
Duke University Medical Center
North Carolina, USA
Gary Lyman MD
Professor of Medicine and Director of Health Services and
Outcomes Research in Oncology
Duke University School of Medicine and the Duke Comprehensive Cancer Center
Fee / Administrative Details:
The registration fee at our VIP Discount Rate is $3,105 USD (regular rate $3,450 USD). This includes lunch and refreshments throughout the day. Accommodation costs are not included. Delegates can register on-line or by completing the booking form and returning it together with the appropriate payment to Cambridge Healthtech Institute. Please retain a copy of the booking form for your records. Details of the venue will be supplied on registration.
Schedule:
November 19: November 20:
8:30 am – 5:30 pm 9:00 am – 2:15 pm